New research shows that GLP-1 receptor agonists (GLP-1RAs) are linked to a increased risk of thyroid carcinomas. The hazard ratio stands at 1.58 (95% CI: 1.27-1.95) after 1-3 years of use. On top of that, these medications raise the risk of medull…